Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents.
about
Immunization of children with secondary immunodeficiencyInfluenza vaccination in HIV-positive subjects: latest evidence and future perspectiveHIV virological suppression influences response to the AS03-adjuvanted monovalent pandemic influenza A H1N1 vaccine in HIV-infected childrenImmunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for childrenMeta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines.Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults.Immunogenicity and tolerability after two doses of non-adjuvanted, whole-virion pandemic influenza A (H1N1) vaccine in HIV-infected individuals.Aflunov®: a vaccine tailored for pre-pandemic and pandemic approaches against influenza.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theGuidance on vaccination of HIV-infected children in Europe.Influenza vaccination in patients with end-stage renal disease.CpG-mediated augmentation of CD8+ T-cell responses in mice is attenuated by a water-in-oil emulsion (Montanide ISA-51) but enhanced by an oil-in-water emulsion (IDRI SE).Long-term immunogenicity after one and two doses of a monovalent MF59-adjuvanted A/H1N1 Influenza virus vaccine coadministered with the seasonal 2009-2010 nonadjuvanted Influenza virus vaccine in HIV-infected children, adolescents, and young adults i
P2860
Q26801474-50972A85-D454-4CF0-8DB8-EBDE01AFBDE7Q27007483-4261828E-AA92-4128-84A5-ACBD0DF1DF83Q30359207-BFF9C4BF-7737-4BCA-BFF0-4C9FAC708D97Q30371111-E2EABF83-1C2F-4F61-8E0A-18E5D4682AFCQ30407050-DBCD78A1-AF55-4E5B-8CF3-3F4A2FDA9529Q30417077-34B3BD09-D61A-488C-980B-B296365E7608Q30417245-CBD05085-980B-4E32-A7BA-ABCFA435C314Q30424161-82DA9A5F-5386-49FB-9CBE-E83A7E9AD1A3Q34212799-AEEA70A5-09EF-446C-9519-B7796D71E028Q34251138-357CB025-B2E8-4939-9949-5ECC376812D0Q38516153-069C176C-B5CB-440A-94B8-43FFBF5F6B61Q40724264-4DE8E924-98E8-438A-9866-82DFF6A26096Q57103712-7E1C99C6-9140-4639-A1C8-911B05D80214
P2860
Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Pandemic influenza A/H1N1 vacc ...... cted children and adolescents.
@ast
Pandemic influenza A/H1N1 vacc ...... cted children and adolescents.
@en
type
label
Pandemic influenza A/H1N1 vacc ...... cted children and adolescents.
@ast
Pandemic influenza A/H1N1 vacc ...... cted children and adolescents.
@en
prefLabel
Pandemic influenza A/H1N1 vacc ...... cted children and adolescents.
@ast
Pandemic influenza A/H1N1 vacc ...... cted children and adolescents.
@en
P2093
P1433
P1476
Pandemic influenza A/H1N1 vacc ...... cted children and adolescents.
@en
P2093
Anna Plebani
Antonia Valzano
Carlotta Galeone
Cristina Daleno
Domenico Serra
Francesca Tel
Giulia Prunotto
Irene Picciolli
Laura Tagliaferri
Susanna Esposito
P304
P356
10.1016/J.VACCINE.2010.12.047
P407
P577
2011-01-01T00:00:00Z